Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Topical Sm29 in Gold Nanoparticles With Intravenous Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania Braziliensis: A Randomized Controlled Trial.

NCT06000514 is registered in ClinicalTrials.gov with Hospital Universitário Professor Edgard Santos as lead sponsor.

NCT NCT06000514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06000514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Topical Sm29 in Gold Nanoparticles With Intravenous Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania Braziliensis: A Randomized Controlled Trial.
Lead sponsor
Hospital Universitário Professor Edgard Santos
Phase
Phase 1/2
Overall status
Completed
Start date
January 17, 2019
Completion date
July 7, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, american